<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21192886</article-id>
      <article-id pub-id-type="pmc">3204624</article-id>
      <article-id pub-id-type="publisher-id">10-0397</article-id>
      <article-id pub-id-type="doi">10.3201/eid1701.100397</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ceftriaxone-Resistant <italic>Neisseria gonorrhoeae</italic>, Japan</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ohnishi</surname>
            <given-names>Makoto</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saika</surname>
            <given-names>Takeshi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoshina</surname>
            <given-names>Shinji</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iwasaku</surname>
            <given-names>Kazuhiro</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakayama</surname>
            <given-names>Shu-ichi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watanabe</surname>
            <given-names>Haruo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kitawaki</surname>
            <given-names>Jo</given-names>
          </name>
        </contrib>
        <aff id="aff1">Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (M. Ohnishi, S. Nakayama, H. Watanabe);</aff>
        <aff id="aff2">Mitsubishi Chemical Medience Corporation, Tokyo (T. Saika); Hoshina Clinic, Kyoto, Japan (S. Hoshina);</aff>
        <aff id="aff3">Kyoto Prefectural University of Medicine, Kyoto (K. Iwasaku, J. Kitawaki)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Makoto Ohnishi, Department of Bacteriology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan, email: <email xlink:href="ohnishi7@nih.go.jp">ohnishi7@nih.go.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>1</issue>
      <fpage>148</fpage>
      <lpage>149</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Neisseria gonorrhoeae</kwd>
        <kwd>antimicrobial resistance</kwd>
        <kwd>sexually transmitted diseases</kwd>
        <kwd>STD</kwd>
        <kwd>ceftriaxone</kwd>
        <kwd>sex workers</kwd>
        <kwd>gonorrhea</kwd>
        <kwd>bacteria</kwd>
        <kwd>Japan</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Spread of multidrug-resistant <italic>Neisseria gonorrhoeae</italic> is a major public health concern. Effective antimicrobial therapy is a key element in gonorrhea control. However, <italic>N. gonorrhoeae</italic> has developed resistance to multiple classes of antimicrobial drugs, including &#x3B2;-lactams, tetracyclines, and fluoroquinolones (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref><italic>&#x2013;</italic><xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Even an extended-spectrum oral cephalosporin-resistant, cefixime-resistant <italic>N. gonorrhoeae</italic> has emerged, and cefixime has now been withdrawn from use in Japan. Best practice treatment is limited to injectable extended-spectrum cephalosporins, such as ceftriaxone and spectinomycin. The emergence of ceftriaxone-resistant <italic>N. gonorrhoeae</italic> threatens effective disease control.</p>
    <p>We identified a novel ceftriaxone-resistant <italic>N. gonorrhoeae</italic> isolated from a 31-year-old female commercial sex worker; MIC of ceftriaxone for this isolate was high (2 &#xB5;g/mL). The woman visited a clinic in Kyoto for a routine examination for sexually transmitted infections in January 2009. Although she had no obvious symptoms or signs, a throat sample collected on her first visit yielded a positive result for <italic>N. gonorrhoeae</italic> by the strand displacement amplification test (ProbeTec ET, Becton Dickinson, Franklin Lakes, NJ, USA), but a vaginal sample taken at the same time was negative. After 2 weeks, another throat sample was positive for <italic>N. gonorrhoeae</italic> when cultured on Thayer-Martin medium, and the patient subsequently received 1 g ceftriaxone intravenously. Her pharyngeal sample was also <italic>N. gonorrhoeae</italic> positive by strand displacement amplification test on the third visit 2 weeks later, and further ceftriaxone treatment was prescribed. However, a culture for test of cure was not conducted because reinfection was considered. A negative result was finally obtained in April 2009.</p>
    <p>The culture showed positive reactions in oxidase and catalase tests. Gram staining showed gram-negative diplococci. The ID-test HN-20 Rapid system (Nissui, Tokyo, Japan) classified the bacterium as <italic>N. gonorrhoeae</italic>. Susceptibility was determined by the agar dilution method (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). For this strain, named H041, MIC of ceftriaxone was high (2 &#xB5;g/mL), and the strain was highly resistant to penicillin G (4 &#xB5;g/mL), cefixime (8 &#xB5;g/mL), and levofloxacin (32 &#xB5;g/mL). However, it demonstrated susceptibility to spectinomycin (16 &#xB5;g/mL) and reduced susceptibility to azithromycin (0.5 &#xB5;g/mL).</p>
    <p>To characterize the ceftriaxone-resistant <italic>N. gonorrhoeae</italic> H041, multilocus sequence typing characterized the strain as ST7363 (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>), which is the predominant sequence type (ST) among cefixime-resistant clones (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). <italic>N. gonorrhoea</italic> multiantigen sequence typing (NG-MAST) was also performed (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). The NG-MAST strategy uses 2 genes, <italic>por</italic> and <italic>tbpB</italic>, for porin and a transferrin-binding protein, respectively. NG-MAST indicated that the strain H041 was ST4220 and contained the <italic>por2594</italic> allele and the <italic>tbpB10</italic> allele. NG-MAST 4220 is a novel ST. However, the <italic>tbpB10</italic> allele is the most frequently observed allele (76.5%) among multilocus sequence typing-ST7363 <italic>N. gonorrhoeae</italic> strains (n = 81) (M. Ohnishi, unpub. data).</p>
    <p>Molecular typing suggested that the novel ceftriaxone-resistant <italic>N. gonorrhoeae</italic>, H041, is closely related to the ST7363 cefixime-resistant <italic>N. gonorrhoeae</italic>. Therefore, we compared <italic>Spe</italic>I-digested genomic DNA banding patterns of strain H041 with those of other <italic>N. gonorrhoeae</italic> strains by using pulsed-field gel electrophoresis as described (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Four ST7363 strains, including <italic>N. gonorrhoeae</italic> H041, and 4 ST1901 strains (another major ST among cefixime-resistant <italic>N. gonorrhoeae</italic> strains) (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>) were analyzed. The banding pattern of <italic>Spe</italic>I digested H041 genomic DNA was similar to that of other ST7363 strains and indistinguishable from that of cefixime-resistant but ceftriaxone-susceptible NG0207 (<xref ref-type="fig" rid="F1">Figure</xref>).</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Pulsed-field gel electrophoresis patterns of ceftriaxone-resistant <italic>Neisseria gonorrhoeae</italic> strain H041 and other multilocus sequence typing (MLST) ST7363 and ST1901 strains. <italic>Spe</italic>I-digested genomic DNA from ceftriaxone-resistant <italic>N. gonorrhoeae</italic> H041, 3 of the MLST ST7363 strains and 4 of the MLST ST1901 strains were analyzed by pulsed-field gel electrophoresis. A lambda ladder standard (Bio-Rad, Hercules, CA, USA) was used as a molecular size marker.</p>
      </caption>
      <graphic xlink:href="10-0397-F"/>
    </fig>
    <p>We describe the emergence of ceftriaxone-resistant <italic>N. gonorrhoeae</italic>, isolated from a pharyngeal specimen from a female commercial sex worker. At 2 &#xB5;g/mL, the MIC was 4-fold higher than that of the previously reported ceftriaxone nonsusceptible strain (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). Our susceptibility testing suggests that only azithromycin and spectinomycin are effective drugs for treating this strain. In this case, eradication was successful, although <italic>N. gonorrhoeae</italic> colonization of the pharynx may just be tempory because the pharynx is not an ideal site for <italic>N. gonorrhoeae</italic> growth. From the routine examinations of commercial sex workers during January&#x2013;March 2009, 40 <italic>N. gonorrhoeae</italic> were isolated in the clinic, but no other ceftriaxone-resistant strains were isolated. There is no evidence of dissemination of this strain in Kyoto.</p>
    <p>Three independent molecular subtyping methods indicated that the ceftriaxone-resistant H041 strain was <italic>N. gonorrhoeae</italic>, and it might originate from an ST7363 cefixime-resistant <italic>N. gonorrhoeae</italic> clone. There are several possible mechanisms for the acquisition of resistance, including formation of a new mosaic type <italic>penA</italic> allele as <italic>penA-X</italic> cefixime resistance and acquisition of an extended-spectrum &#x3B2;-lactamase gene. The H041 strain did not produce &#x3B2;-lactamase in a nitrocephin test. Further molecular analysis is needed to elucidate the precise mechanism of the ceftriaxone resistance of the H041 strain.</p>
    <p>The emergence of ceftriaxone-resistant <italic>N</italic>. <italic>gonorrhoeae</italic> raises concerns for controlling gonorrhea because ceftriaxone is widely recommended and the first-line treatment for gonorrhea around the world. <italic>N. gonorrhoeae</italic> has a potential to gain an extraordinarily high MIC to ceftriaxone. Surveillance for ceftriaxone-resistant <italic>N</italic>. <italic>gonorrhoeae</italic> should be strengthened.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article:</italic> Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, et al. Ceftriaxone-resistant <italic>Neisseria gonorrhoeae</italic>, Japan [letter]. Emerg Infect Dis [serial on the Internet]. 2011 Jan [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1701.100397">http://dx.doi.org/10.3201/eid1701.100397</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank Hiroko Matsuoka for her technical assistance.</p>
      <p>This study was supported by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan (H21-Shinko-Ippan-001, and &#x2212;012).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tapsall</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Ndowa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Unemo</surname> <given-names>M</given-names></string-name> <article-title>Meeting the public health challenge of multidrug- and extensively drug-resistant <italic>Neisseria gonorrhoeae.</italic></article-title> <source>Expert Rev Anti Infect Ther</source>. <year>2009</year>;<volume>7</volume>:<fpage>821</fpage>&#x2013;<lpage>34</lpage>   <pub-id pub-id-type="doi">10.1586/eri.09.63</pub-id><pub-id pub-id-type="pmid">19735224</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Workowski</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Berman</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Douglas</surname> <given-names>JM</given-names> <suffix>Jr</suffix></string-name> <article-title>Emerging antimicrobial resistance in <italic>Neisseria gonorrhoeae</italic>: urgent need to strengthen prevention strategies.</article-title> <source>Ann Intern Med</source>. <year>2008</year>;<volume>148</volume>:<fpage>606</fpage>&#x2013;<lpage>13</lpage> <pub-id pub-id-type="pmid">18413622</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tapsall</surname> <given-names>J</given-names></string-name> <article-title>Antibiotic resistance in <italic>Neisseria gonorrhoeae</italic> is diminishing available treatment options for gonorrhea: some possible remedies.</article-title> <source>Expert Rev Anti Infect Ther</source>. <year>2006</year>;<volume>4</volume>:<fpage>619</fpage>&#x2013;<lpage>28</lpage>   <pub-id pub-id-type="doi">10.1586/14787210.4.4.619</pub-id><pub-id pub-id-type="pmid">17009941</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="book"><collab>Clinical Laboratory Standards Institute</collab> Performance standards for antimicrobial susceptibility testing, 19th informational supplement. CLSI document M100&#x2013;S19. Wayne (PA): The Institute; <year>2009</year></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="book"><string-name><surname>Jolley</surname> <given-names>KA</given-names></string-name> Multi-locus sequence typing. In: Pollard AJ Maiden MCJ, editors. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; <year>2001</year> p. 173&#x2013;86.</mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Ohnishi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ono</surname> <given-names>E</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Oya</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kuroki</surname> <given-names>T</given-names></string-name>, <etal/> <article-title>Spreading of a chromosomal cefixime resistant <italic>penA</italic> gene among different <italic>Neisseria gonorrhoeae</italic> lineages.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2010</year>;<volume>54</volume>:<fpage>1060</fpage>&#x2013;<lpage>7</lpage>   <pub-id pub-id-type="doi">10.1128/AAC.01010-09</pub-id><pub-id pub-id-type="pmid">20028823</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Martin</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Ison</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Aanensen</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Fenton</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Spratt</surname> <given-names>BG</given-names></string-name> <article-title>Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area.</article-title> <source>J Infect Dis</source>. <year>2004</year>;<volume>189</volume>:<fpage>1497</fpage>&#x2013;<lpage>505</lpage>   <pub-id pub-id-type="doi">10.1086/383047</pub-id><pub-id pub-id-type="pmid">15073688</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Ito</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yasuda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yokoi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>S</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ishihara</surname> <given-names>S</given-names></string-name>, <etal/> <article-title>Remarkable increase in central Japan in 2001&#x2013;2002 of <italic>Neisseria gonorrhoeae</italic> isolates with decreased susceptibility to penicillin, tetracycline, oral cepharosporins, and fluoroquinolones.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2004</year>;<volume>48</volume>:<fpage>3185</fpage>&#x2013;<lpage>7</lpage>   <pub-id pub-id-type="doi">10.1128/AAC.48.8.3185-3187.2004</pub-id><pub-id pub-id-type="pmid">15273147</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tanaka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nakayama</surname> <given-names>H</given-names></string-name>, <string-name><surname>Huruya</surname> <given-names>K</given-names></string-name>, <string-name><surname>Konomi</surname> <given-names>I</given-names></string-name>, <string-name><surname>Irie</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kanayama</surname> <given-names>A</given-names></string-name>, <etal/> <article-title>Analysis of mutations within multiple genes associated with resistance in a clinical isolate of <italic>Neisseria gonorrhoeae</italic> with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.</article-title> <source>Int J Antimicrob Agents</source>. <year>2006</year>;<volume>27</volume>:<fpage>20</fpage>&#x2013;<lpage>6</lpage>   <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.08.021</pub-id><pub-id pub-id-type="pmid">16318912</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
